218 related articles for article (PubMed ID: 10084057)
1. New plasminogen activators: a clinical review.
Ross AM
Clin Cardiol; 1999 Mar; 22(3):165-71. PubMed ID: 10084057
[TBL] [Abstract][Full Text] [Related]
2. Thrombolytic therapy in acute myocardial infarction--selected recent developments.
Bode C; Nordt TK; Runge MS
Ann Hematol; 1994 Oct; 69(4):S35-40. PubMed ID: 7948298
[TBL] [Abstract][Full Text] [Related]
3. Newer thrombolytic drugs for acute myocardial infarction.
Reddy DS
Indian J Exp Biol; 1998 Jan; 36(1):1-15. PubMed ID: 9536645
[TBL] [Abstract][Full Text] [Related]
4. Innovative approaches to plasminogen activator therapy.
Haber E; Quertermous T; Matsueda GR; Runge MS
Science; 1989 Jan; 243(4887):51-6. PubMed ID: 2492113
[TBL] [Abstract][Full Text] [Related]
5. Current state of thrombolytic therapy.
Vorchheimer DA
Curr Cardiol Rep; 1999 Sep; 1(3):212-20. PubMed ID: 10980844
[TBL] [Abstract][Full Text] [Related]
6. Influence of time to treatment on early infarct-related artery patency after different thrombolytic regimens. ALKK-Study Group.
Zeymer U; Tebbe U; Essen Rv; Haarmann W; Neuhaus KL
Am Heart J; 1999 Jan; 137(1):34-8. PubMed ID: 9878934
[TBL] [Abstract][Full Text] [Related]
7. Intravenous thrombolytic therapy with a combination of single-chain urokinase-type plasminogen activator and recombinant tissue-type plasminogen activator in acute myocardial infarction.
Bode C; Schuler G; Nordt T; Schönermark S; Baumann H; Richardt G; Dietz R; Gurewich V; Kübler W
Circulation; 1990 Mar; 81(3):907-13. PubMed ID: 2106403
[TBL] [Abstract][Full Text] [Related]
8. [Thrombolytic therapy of ischemic heart disease].
Kanmatsuse K; Nagao K; Kikushima K; Shioiri K
Nihon Naika Gakkai Zasshi; 1997 Sep; 86(9):1625-8. PubMed ID: 9410972
[No Abstract] [Full Text] [Related]
9. [Tissue-type plasminogen activator and pro-urokinase--new fibrinolytic agents in the treatment of myocardial infarction].
Czyrski J
Wiad Lek; 1989 Apr; 42(7):450-2. PubMed ID: 2516932
[TBL] [Abstract][Full Text] [Related]
10. [Coronary thrombolysis in patients with acute myocardial infarction].
Kambara H; Fudo T; Ono S
Kokyu To Junkan; 1992 Jun; 40(6):537-47. PubMed ID: 1620990
[No Abstract] [Full Text] [Related]
11. Thrombolytic therapy.
Collen D; Lijnen HR
Ann N Y Acad Sci; 1991; 614():259-69. PubMed ID: 1902640
[No Abstract] [Full Text] [Related]
12. [New thrombolytic agents in myocardial infarction].
Charbonnier B; Lang M; Brochier M
Arch Mal Coeur Vaiss; 1987 Nov; 80(12):1785-91. PubMed ID: 3128222
[TBL] [Abstract][Full Text] [Related]
13. Coronary arterial thrombolysis with low-dose synergistic combinations of recombinant tissue-type plasminogen activator (rt-PA) and recombinant single-chain urokinase-type plasminogen activator (rscu-PA) for acute myocardial infarction.
Collen D; Van de Werf F
Am J Cardiol; 1987 Sep; 60(7):431-4. PubMed ID: 3115077
[TBL] [Abstract][Full Text] [Related]
14. Differential effects of tissue plasminogen activator and streptokinase on infarct size and on rate of enzyme release: influence of early infarct related artery patency. The GUSTO Enzyme Substudy.
Baardman T; Hermens WT; Lenderink T; Molhoek GP; Grollier G; Pfisterer M; Simoons ML
Eur Heart J; 1996 Feb; 17(2):237-46. PubMed ID: 8732377
[TBL] [Abstract][Full Text] [Related]
15. A fresh look at the molecular pharmacology of plasminogen activators: from theory to test tube to clinical outcomes.
Smalling RW
Am J Health Syst Pharm; 1997 Nov; 54 Suppl 1():S17-22. PubMed ID: 9397233
[TBL] [Abstract][Full Text] [Related]
16. Effects of lipoprotein (a) on success rate of thrombolytic therapy in acute myocardial infarction.
von Hodenberg E; Kreuzer J; Hautmann M; Nordt T; Kübler W; Bode C
Am J Cardiol; 1991 Jun; 67(16):1349-53. PubMed ID: 1828324
[TBL] [Abstract][Full Text] [Related]
17. [Thrombolytic therapy in acute myocardial infarct].
Bode C; Baumann H; von Hodenberg E; Kübler W
Med Klin (Munich); 1992 Feb; 87(2):64-9. PubMed ID: 1542285
[No Abstract] [Full Text] [Related]
18. Sequential combination thrombolytic therapy for acute myocardial infarction: results of the Pro-Urokinase and t-PA Enhancement of Thrombolysis (PATENT) Trial.
Zarich SW; Kowalchuk GJ; Weaver WD; Loscalzo J; Sassower M; Manzo K; Byrnes C; Muller JE; Gurewich V
J Am Coll Cardiol; 1995 Aug; 26(2):374-9. PubMed ID: 7608437
[TBL] [Abstract][Full Text] [Related]
19. [Staphylokinase for a better thrombolytic treatment of heart and platelet diseases].
Vanderschueren S
Verh K Acad Geneeskd Belg; 2000; 62(1):69-75. PubMed ID: 10769618
[TBL] [Abstract][Full Text] [Related]
20. Coronary thrombolysis in patients with acute myocardial infarction by intravenous infusion of synergic thrombolytic agents.
Collen D; Stump DC; Van de Werf F
Am Heart J; 1986 Nov; 112(5):1083-4. PubMed ID: 3096127
[No Abstract] [Full Text] [Related]
[Next] [New Search]
